You have 9 free searches left this month | for more free features.

City

Brisbane (1)

Darmstadt (1)

Condition

Malaria (1)

Malaria Infection (1)

Malaria Recrudescence (1)

Malaria,Falciparum (1)

Parasitemia (1)

Parasitic Disease (1)

Protozoan Infections (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Medicines for Malaria Venture (1)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)

Collaborator

Children's Health Queensland Hospital and Health Service (1)

QIMR Berghofer Medical Research Institute (1)

Southern Star Research Pty Ltd. (1)

Swiss BioQuant A.G., Switzerland (1)

Intervention

pyronaridine (2)

atovaquone-proguanil (1)

m5717 200 mg (1)

m5717 60 mg (1)

m5717 660mg (1)

p. falciparum ibsm infection (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

pyronaridine

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)

Not yet recruiting

Malaria Infection

M5717 60 mg
+4 more

Darmstadt, Germany

Research Site

Aug 2, 2023

Malaria,Falciparum, Malaria, Malaria Recrudescence Trial in Brisbane (Pyronaridine, P. falciparum IBSM infection)

Completed

Malaria,Falciparum
+5 more

Pyronaridine
P. falciparum IBSM infection

Brisbane, Queensland, Australia
+1 more

Nov 3, 2022